Bank of America’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-21,854
| Closed | -$327K | – | 8689 |
|
|
2022
Q4 | $327K | Sell |
21,854
-32,635
| -60% | -$452K | ﹤0.01% | 5651 |
|
|
2022
Q3 | $449K | Buy |
54,489
+5,537
| +11% | +$42.5K | ﹤0.01% | 5489 |
|
|
2022
Q2 | $321K | Sell |
48,952
-76
| -0.2% | -$368 | ﹤0.01% | 5752 |
|
|
2022
Q1 | $274K | Sell |
49,028
-17,431
| -26% | -$71.8K | ﹤0.01% | 6262 |
|
|
2021
Q4 | $311K | Sell |
66,459
-26,198
| -28% | -$163K | ﹤0.01% | 6219 |
|
|
2021
Q3 | $573K | Buy |
92,657
+62,765
| +210% | +$375K | ﹤0.01% | 5545 |
|
|
2021
Q2 | $197K | Sell |
29,892
-4,340
| -13% | -$29.9K | ﹤0.01% | 6110 |
|
|
2021
Q1 | $250K | Buy |
34,232
+16,111
| +89% | +$139K | ﹤0.01% | 5880 |
|
|
2020
Q4 | $105K | Buy |
18,121
+5,088
| +39% | +$29.1K | ﹤0.01% | 5961 |
|
|
2020
Q3 | $78K | Sell |
13,033
-28,326
| -68% | -$140K | ﹤0.01% | 5808 |
|
|
2020
Q2 | $214K | Buy |
41,359
+38,729
| +1,473% | +$244K | ﹤0.01% | 5198 |
|
|
2020
Q1 | $10K | Buy |
2,630
+1,000
| +61% | +$4.96K | ﹤0.01% | 6372 |
|
|
2019
Q4 | $10K | Hold |
1,630
| – | – | ﹤0.01% | 6656 |
|
|
2019
Q3 | $14K | Sell |
1,630
-56,543
| -97% | -$421K | ﹤0.01% | 6662 |
|
|
2019
Q2 | $391K | Buy |
58,173
+56,465
| +3,306% | +$484K | ﹤0.01% | 5227 |
|
|
2019
Q1 | $14K | Sell |
1,708
-4,669
| -73% | -$48.2K | ﹤0.01% | 6587 |
|
|
2018
Q4 | $103K | Buy |
6,377
+3,648
| +134% | +$80.3K | ﹤0.01% | 5900 |
|
|
2018
Q3 | $90K | Buy |
2,729
+1,958
| +254% | +$50.3K | ﹤0.01% | 5927 |
|
|
2018
Q2 | $17K | Sell |
771
-2,964
| -79% | -$70.3K | ﹤0.01% | 6564 |
|
|
2018
Q1 | $108K | Buy |
3,735
+3,135
| +523% | +$91.7K | ﹤0.01% | 5700 |
|
|
2017
Q4 | $17K | Hold |
600
| – | – | ﹤0.01% | 6474 |
|
|
2017
Q3 | $22K | Buy |
600
+100
| +20% | +$3.09K | ﹤0.01% | 6242 |
|
|
2017
Q2 | $11K | Hold |
500
| – | – | ﹤0.01% | 6411 |
|
|
2017
Q1 | $3K | Sell |
500
-10
| -2% | -$72 | ﹤0.01% | 6757 |
|
|
2016
Q4 | $3K | Sell |
510
-40
| -7% | -$267 | ﹤0.01% | 6808 |
|
|
2016
Q3 | $5K | Hold |
550
| – | – | ﹤0.01% | 6640 |
|
|
2016
Q2 | $5K | Buy |
550
+500
| +1,000% | +$4.82K | ﹤0.01% | 6696 |
|
|
2016
Q1 | $0 | Sell |
50
-297
| -86% | -$2.94K | ﹤0.01% | 7497 |
|
|
2015
Q4 | $5K | Buy |
347
+200
| +136% | +$2.38K | ﹤0.01% | 6897 |
|
|
2015
Q3 | $2K | Sell |
147
-3
| -2% | -$43 | ﹤0.01% | 6996 |
|
|
2015
Q2 | $3K | Buy |
+150
| New | +$2.7K | ﹤0.01% | 6992 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 7774 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 8114 |
|
|
2014
Q3 | – | Sell |
-23,380
| Closed | -$297K | – | 8280 |
|
|
2014
Q2 | $428K | Buy |
23,380
+23,105
| +8,402% | +$301K | ﹤0.01% | 4771 |
|
|
2014
Q1 | $4K | Sell |
275
-404
| -59% | -$7.26K | ﹤0.01% | 7427 |
|
|
2013
Q4 | $12K | Buy |
679
+258
| +61% | +$5.17K | ﹤0.01% | 7237 |
|
|
2013
Q3 | $9K | Sell |
421
-1,235
| -75% | -$28.3K | ﹤0.01% | 7215 |
|
|
2013
Q2 | $41K | Buy |
+1,656
| New | +$70.8K | ﹤0.01% | 6672 |
|
Bank of America's AVEO Position: Q1 2023 in Review
Bank of America sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 21,854 shares — an estimated $327K sold.
Bank of America first reported a position in AVEO in Q2 2013 and held it in 36 quarters. The position peaked at $573K in Q3 2021. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.
- Bank of America reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
- Bank of America sold 21,854 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $327K.
- Bank of America first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 36 quarters.
- Bank of America's AVEO Pharmaceuticals, Inc. position peaked at $573K in Q3 2021.
- 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.
Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.